A specialized forensic diagnostic protocol for detecting N-ethylpentedrone (NEPD) by targeting its specific Phase-I and Phase-II metabolic markers in urine. The approach utilizes UHPLC-QTOF-HRMS with dual-ionization to ensure comprehensive detection of both parent compounds and glucuronidated metabolites.
The PESTEL analysis reveals a strong alignment between the technical capabilities of UHPLC-QTOF-HRMS and the urgent legal and political need to track emerging NPS. While the high cost of equipment presents an economic barrier, the critical requirement for legally defensible evidence in forensic settings creates a high-value niche for this specialized panel.
Political2
Economic2
Social2
Technological2
Environmental2
Legal2
The viability of a forensic screening panel is heavily dependent on legal standards for evidence and the evolving regulatory landscape of new psychoactive substances. · Generated 2026-09-10 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated